🍪 CompoundTalk uses cookies to improve your experience, analyze traffic, and personalize content. By continuing to use this site, you agree to our Cookie Policy.
Evidence-based GLP-1 & peptide discussion since 2023
ForumsMetabolic Health & DiabetesAdiponectin and leptin changes on GLP-1 therapy — 12 month update Page 3

Adiponectin and leptin changes on GLP-1 therapy — 12 month update

Dr.PathRoch Sun, Oct 6, 2024 at 8:34 PM 12 replies 1,878 viewsPage 3 of 3
WendyG_ATL
Member
1,023
5,678
Apr 2024
Georgia
Oct 8, 2024 at 8:06 PM#11
TinaHashiRN said:
Anxiety increase on mental health: counterintuitive, but losing weight rapidly triggered anxiety for me.

Saving this. It is the first explanation that did not require me to already understand it. I will report back once I have actually tried it.

Last edited: Oct 8, 2024 at 9:06 PM
26 1Dr.SurgeonPGH, rachel_ABQ, traveltech_sara and 23 others
Reply Quote Save Share Report
Dr.SleepRoch
Senior Member
1,123
5,678
Apr 2024
Rochester, MN
Oct 8, 2024 at 11:30 PM#12

Clinical perspective, offered as context rather than as advice.

Recovering from an eating disorder and using mental health: this is a complex situation and I want to be transparent about it.

I have a history of binge eating disorder. My psychiatrist, therapist, and prescribing doctor all collaborate on my care. The GLP-1 agonist has actually been therapeutic — it removes the biological urgency of binge impulses without relying on restriction.

This is NOT appropriate for all ED patients. Anorexia, bulimia, and restrictive EDs require different approaches. But for BED specifically, the evidence and my personal experience are positive. Always involve your mental health team.

Last edited: Oct 9, 2024 at 3:30 AM
25 0kim_atl_prep, sarah_TO, wendy_avl and 22 others
Reply Quote Save Share Report
Dr.KarenChen
VIP Member
4,210
24,567
Nov 2023
San Francisco, CA
Oct 9, 2024 at 2:54 AM#13
roxy_nash said:
Therapy insights from my mental health journey: my therapist introduced me to the concept of "identity updating" — the psychological work of becoming…
roxy_nash said:
...mental health should only be used alongside therapy...

I'd say therapy should be AVAILABLE to all GLP-1 patients, but requiring it as a precondition for treatment would create an access barrier.

Not everyone can afford therapy. Not everyone needs it. Some people do just fine with medication + lifestyle changes. But for those with emotional eating, body image issues, or disordered eating history, therapy is extremely valuable.

My recommendation: make mental health screening part of the initial assessment, offer therapy as a recommended adjunct, but don't gatekeep medication access behind it.

24 24TomFromTexas, mike.trainer_LA, sarah_nash92 and 21 others
Reply Quote Save Share Report

Sigma-Aldrich — Research-Grade Standards

Certified reference materials, analytical reagents, and research-grade standards for peptide verification. Trusted by laboratories worldwide.

Shop Reference Standards
quinn_sf
Member
489
2,123
Jun 2024
San Francisco, CA
Oct 9, 2024 at 6:18 AM#14
Dr.PathRoch said:
The mental-health dimension is under-measured in the trial literature and the reports here are consistent enough to take seriously.

When to call your doctor about mental health side effects — a reference I wish I'd had:

Call immediately:

  • Severe abdominal pain (could be pancreatitis)
  • Vision changes (thyroid concern)
  • Lump in neck (thyroid nodule)
  • Severe vomiting/can't keep fluids down for 24h+

Schedule an appointment:

  • Persistent nausea beyond 4 weeks
  • Significant hair loss
  • Mood changes or depression
  • Gallbladder symptoms (RUQ pain after eating)
23 23andrew_nyc, Dr.EndoEP, GraceAZ_72 and 20 others
Reply Quote Save Share Report
mike_mod
Moderator
7,234
19,823
Nov 2023
New York
Online
Oct 9, 2024 at 9:42 AM#15

Moderator note: a couple of off-topic posts removed.

22 22PurityPaulOR, MaxMetOK, MounjBrad and 19 others
Reply Quote Save Share Report

Similar Threads

SUSTAIN-6 to SELECT — the cardiovascular evidence timeline14 replies
GLP-1 and insulin resistance — HOMA-IR improvement data17 replies
Metabolic syndrome reversal criteria — how GLP-1 addresses all 55 replies
A1C target achievement rates — sema vs tirz comparison8 replies
SURPASS-CVOT: tirzepatide cardiovascular outcomes trial design3 replies
ForumsNewTrendingMembersAccount

Log In

Forgot password?
No account? Register